Evidence map›Paper›PMID 33985430›Full record

ArticleBMC gastroenterology2021

Schistosoma mansoni-related periportal fibrosis; can we use APRI and PSDR levels in the real-time selection of patients for targeted endoscopy in a resource-limited setting? A case-control study.

Daniel W Gunda, Elizabeth F Mtui, Paulina M Manyiri, David C Majinge, Semvua B Kilonzo, Humphrey D Mazigo, Benson R Kidenya

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Assessment of periportal fibrosis inWorld journal of hepatology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel W GundaDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, 1464, Mwanza, Tanzania. daniel_rev2002@yahoo.com.ORCID http://orcid.org/0000-0002-2701-9321
Elizabeth F MtuiDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, 1464, Mwanza, Tanzania.
Paulina M ManyiriDepartment of Internal Medicine, Bugando Medical Centre, 1370, Mwanza, Tanzania.
David C MajingeDepartment of Internal Medicine, Bugando Medical Centre, 1370, Mwanza, Tanzania.
Semvua B KilonzoDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, 1464, Mwanza, Tanzania.
Humphrey D MazigoDepartment of Parasitology, Catholic University of Health and Allied Sciences, 1464, Mwanza, Tanzania.
Benson R KidenyaDepartment of Biochemistry and Molecular Biology, Catholic University of Health and Allied Sciences, 1464, Mwanza, Tanzania.
Catholic University of Health and Allied Sciences · TZBugando Medical Centre · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchistosoma mansoni related hepatic fibrosis is usually associated with hemodynamic alteration with increased mortality due to bleeding varices. The diagnosis of varices before bleeding imposes a big challenge in resource-limited countries using endoscopy. Published evidence on the utility of non-invasive clinical tools in predicting the presence of varices among patients with S. mansoni related periportal fibrosis is still inadequate including Aspartate to platelet ratio index (APRI) and Platelet to splenic diameter ratio (PSDR) levels. This study describes the determinants of portal varices and assesses the potential utility of the APRI and PSDR level in the discrimination of portal varices among patients with S. mansoni related periportal fibrosis (PPF).

methodsA case-control study using cross-sectional data was done among patients with Schistosoma mansoni related periportal fibrosis at Bugando Medical Centre, in Mwanza Tanzania. The derivation cohort included patients enrolled between 2015 and 2019 and the validation cohort included patients enrolled from 2019 till March 2021. Socio-demographic, laboratory, ultrasound, and upper digestive endoscopic information were analyzed using STATA 13. The prevalence and determinants of varices were determined by logistic regression. The sensitivity and specificity of independent factors were determined to assess their utility in discriminating the presence of portal varices in patients with PPF.

resultsIn total, 250 patients were included in the derivation cohort, 109 (43.6%; 95% CI 37.3-49.9) of them had varices. The odds of having varices were independently increased among patients with higher APRI levels than 1.51, (AOR: 5.8; 95% CI 3.1-11.1; p < 0.001) and PSDR levels that were lower than 5700 (AOR: 5.9; 95% CI 3.2-11.2; p < 0.001). Both APRI and PSDR levels had significantly high sensitivity and specificity in predicting the presence of esophageal varices. However, the combined values of APRI and PSDR had higher specificity than any of the two markers. Of the 200 patients in the validation cohort 94 (47.0%; 95% CI 40.0-54.2) had varices, the discriminative power of the final model and the predictive ability of both APRI, PSDR, and APRI-PSDR combined levels were highly maintained.

conclusionsThis study indicates that varices are a common encounter among patients with S. mansoni related periportal fibrosis and it is independently associated with higher APRI and lower PSDR levels suggesting that these tools are potential discriminators of varices in this subgroup of patients. The reproducibility of these results should further be assessed longitudinally as potential non-invasive tools in selecting patients at high risk of having esophageal varices who could benefit from the targeted endoscopic intervention in a resource-limited setting like ours.

Indexed as

Esophageal and Gastric VaricesSchistosoma mansoniAnimalsAspartic AcidCase-Control StudiesCross-Sectional StudiesEndoscopyHumansLiver CirrhosisPatient SelectionReproducibility of ResultsTanzaniaAspartic AcidAPRI levelsEsophageal varicesNorthwestern TanzaniaPeriportal fibrosisPSDR levels Hepatitis B co-infectionResource-limited settingSchistosoma mansoniValidation of APRI and PSDR use in Schistosoma mansoni PPF

Identifiers

PMID33985430
PMCPMC8117578
OpenAlexW3163161580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.